story of the week
HER2-Targeted Therapy Not Effective in Patients Screened With PRO Onc Assay
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Breast Cancer Research and Treatment
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Use of a Multiplexed Immunoassay (PRO Onc Assay) to Detect HER2 Abnormalities in Circulating Tumor Cells of Women With HER2-Negative Metastatic Breast Cancer: Lack of Response to HER2-Targeted Therapy
Breast Cancer Res Treat 2016 Sep 08;[EPub Ahead of Print], JD Hainsworth, PB Murphy, JR Alemar, BR Daniel, RR Young, DA YardleyFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.